FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22112111000001105: Tafamidis meglumine 20mg capsules 30 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Apr 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1481141000001115 Tafamidis meglumine 20mg capsules 30 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1481151000001117 Tafamidis meglumine 20mg capsules 30 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tafamidis meglumine 20mg capsules 30 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule Has specific active ingredient Tafamidis meglumine true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule Has VMP Tafamidis meglumine 20mg capsules true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Is a True Tafamidis meglumine 20mg capsules 30 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start